Abstract:Pathogenic variants in the MED12 gene located on the X‐chromosome have primarily been reported in males with Lujan‐Fryns syndrome, Ohdo syndrome and the Opits‐Kaveggia syndrome. However, earlier reports of female patients and female mice suggest that MED12 deficiency causes severe malformations. We report a novel example of a MED12 de novo nonsense variant in a female fetus with severe malformations identified by trio‐exome sequencing. This finding further expands the clinical spectrum of MED12‐related disorde… Show more
“…[1][2][3] To our knowledge, this is the second case in which HS was diagnosed in utero. Faergeman et al 4 Many studies have reported that the adoption of a systematic examination including a standardized protocol can achieve a significant increase in the detection rate of anomalies in early gestation. 5,6 Detailed assessment of fetal anatomy is necessary at least in highrisk pregnancies such as those with increased NT, as evidenced by our case.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this is the second case in which HS was diagnosed in utero. Faergeman et al 4 . reported the prenatal diagnosis of a MED12 de novo nonsense variant c.6196 C > T, p.(Gln2066*) in a female fetus identified by exome sequencing.…”
Trio exome sequencing was performed on a female fetus with an increased nuchal translucency, along with nasal bone hypoplasia, suspected cleft palate and abnormal outflow tract of the heart. A de novo heterozygous variant c.5500_5507del, p.(Tyr1834Argfs × 58) in the MED12 gene was detected. Loss‐of‐function variants in MED12 in females are associated with Hardikar syndrome (HS). A follow‐up ultrasound at 15+5 weeks of gestation identified multiple fetal anomalies including bilateral cleft lip and palate, diaphragmatic hernia, atrioventricular septal defect, persistent truncus arteriosus, and bilateral renal pelvis dilation. Fetal autopsy confirmed the prenatal sonographic findings, and the MED12 variant was discussed by our multidisciplinary team to be the cause of fetal anomalies. Our case is the first prenatal one in which HS was diagnosed due to first trimester structural malformations. This case report presents another example of early identification of a major anomaly which allows earlier genetic diagnosis and more time for clinical management.
“…[1][2][3] To our knowledge, this is the second case in which HS was diagnosed in utero. Faergeman et al 4 Many studies have reported that the adoption of a systematic examination including a standardized protocol can achieve a significant increase in the detection rate of anomalies in early gestation. 5,6 Detailed assessment of fetal anatomy is necessary at least in highrisk pregnancies such as those with increased NT, as evidenced by our case.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this is the second case in which HS was diagnosed in utero. Faergeman et al 4 . reported the prenatal diagnosis of a MED12 de novo nonsense variant c.6196 C > T, p.(Gln2066*) in a female fetus identified by exome sequencing.…”
Trio exome sequencing was performed on a female fetus with an increased nuchal translucency, along with nasal bone hypoplasia, suspected cleft palate and abnormal outflow tract of the heart. A de novo heterozygous variant c.5500_5507del, p.(Tyr1834Argfs × 58) in the MED12 gene was detected. Loss‐of‐function variants in MED12 in females are associated with Hardikar syndrome (HS). A follow‐up ultrasound at 15+5 weeks of gestation identified multiple fetal anomalies including bilateral cleft lip and palate, diaphragmatic hernia, atrioventricular septal defect, persistent truncus arteriosus, and bilateral renal pelvis dilation. Fetal autopsy confirmed the prenatal sonographic findings, and the MED12 variant was discussed by our multidisciplinary team to be the cause of fetal anomalies. Our case is the first prenatal one in which HS was diagnosed due to first trimester structural malformations. This case report presents another example of early identification of a major anomaly which allows earlier genetic diagnosis and more time for clinical management.
“…However, known clues to MED12 deficiency by prenatal tests are scarce. By prenatal sonography, agenesis of the corpus callosum (ACC) ( Jiang et al, 2019 ), cleft lip and cleft palate ( Faergeman et al, 2021 ), microphthalmia ( Amodeo et al, 2020 ; Faergeman et al, 2021 ), microretrognathia ( Amodeo et al, 2020 ), heart disease ( Amodeo et al, 2020 ; Faergeman et al, 2021 ), broad thumbs and halluces ( Kato et al, 1994 ; Graham et al, 1999 ), and fetal digital pads ( Clark et al, 2009 ) have been reported in fetal MED12 deficiency; in terms of phenotype, congenital clinodactyly and overriding toes were documented in some of postnatal patients with XLOS ( Patil et al, 2017 ), which indicates possible prenatal ultrasound findings. In the oldest patient in this study, the postnatal findings of hallux rigidus and congenital heart disease (CHD) prompt a diagnosis of MED12 deficiency, although the patient failed to receive a comprehensive genetic test.…”
A fetal clenched hand with overlapping fingers is more common in aneuploidy syndrome and was not well-documented in MED12 deficiency. This study reports the clinical and genetic findings of three affected siblings from a Chinese family. The chromosome karyotype analysis diagram shows that karyotypes of the three children were normal. Trio whole-exome sequencing and Sanger sequencing verification found that there was a MED12 R296Q variant in normal mothers and their two offspring. A pattern of clenched hand with overlapping fingers (clinodactyly) and clubfoot was found in all the three affected siblings by three-dimensional ultrasound. The discovery of this case shows that even if the chromosome karyotype is normal, comprehensive prenatal genetic diagnosis is required when the ultrasound results show a clenched hand with clinodactyly and clubfoot symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.